160 related articles for article (PubMed ID: 19574935)
1. Transvaginal dehydroepiandrosterone: an unconventional proposal to deliver a mysterious androgen that has no receptor or target tissue using a strategy with a new name: hormone precursor replacement therapy (HPRT).
Buster JE
Menopause; 2009; 16(5):858-9. PubMed ID: 19574935
[No Abstract] [Full Text] [Related]
2. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone therapy as female androgen replacement.
Saltzman E; Guay A
Semin Reprod Med; 2006 Apr; 24(2):97-105. PubMed ID: 16633983
[TBL] [Abstract][Full Text] [Related]
6. DHEA replacement for postmenopausal women: placebo or panacea?
Eden JA
Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
[TBL] [Abstract][Full Text] [Related]
7. Estrogen for vulvovaginal symptoms: how low can you go?
Brzezinski A; Benshushan A
Menopause; 2009; 16(5):848-50. PubMed ID: 19564805
[No Abstract] [Full Text] [Related]
8. Female sexual dysfunction and use of hormone therapy in postmenopausal women.
Kovalevsky G
Semin Reprod Med; 2005 May; 23(2):180-7. PubMed ID: 15852204
[TBL] [Abstract][Full Text] [Related]
9. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Martel C; Balser J
Gynecol Endocrinol; 2010 Jul; 26(7):524-32. PubMed ID: 20459349
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.
Bouchard C; Labrie F; Derogatis L; Girard G; Ayotte N; Gallagher J; Cusan L; Archer DF; Portman D; Lavoie L; Beauregard A; Côté I; Martel C; Vaillancourt M; Balser J; Moyneur E;
Horm Mol Biol Clin Investig; 2016 Mar; 25(3):181-90. PubMed ID: 26725467
[TBL] [Abstract][Full Text] [Related]
11. Localization of the androgen-synthesizing enzymes, androgen receptor, and sex steroids in the vagina: possible implications for the treatment of postmenopausal sexual dysfunction.
Bertin J; Dury AY; Ouellet J; Pelletier G; Labrie F
J Sex Med; 2014 Aug; 11(8):1949-61. PubMed ID: 24919541
[TBL] [Abstract][Full Text] [Related]
12. Is vaginal administration the "way out" of the hormone of controversy?
Genazzani AR; Pluchino N
Menopause; 2016 Mar; 23(3):235. PubMed ID: 26859345
[No Abstract] [Full Text] [Related]
13. Dehydroepiandrosterone replacement therapy--panacea, snake oil, or a bit of both?
Chang AY; Ghayee HK; Auchus RJ
Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):442-3. PubMed ID: 18560399
[No Abstract] [Full Text] [Related]
14. Androgens and the brain.
Genazzani AR; Pluchino N; Freschi L; Ninni F; Luisi M
Maturitas; 2007 May; 57(1):27-30. PubMed ID: 17386983
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement Up-to-date. Adrenopause and DHEA replacement therapy].
Ohnaka K; Takayanagi R
Clin Calcium; 2007 Sep; 17(9):1334-40. PubMed ID: 17767021
[TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy for postmenopausal decline in sexual desire: implications of a new study.
Sarrel PM
Menopause; 2006; 13(3):328-30. PubMed ID: 16735927
[No Abstract] [Full Text] [Related]
18. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
19. Consensus Document on substitution therapy with DHEA in the elderly.
; Valenti G; Denti L; Saccò M; Ceresini G; Bossoni S; Giustina A; Maugeri D; Vigna GB; Fellin R; Paolisso G; Barbagallo M; Maggio M; Strollo F; Bollanti L; Romanelli F; Latini M
Aging Clin Exp Res; 2006 Aug; 18(4):277-300. PubMed ID: 17063063
[No Abstract] [Full Text] [Related]
20. [Postmenopausal atrophic colpitis--its local treatment with low-dose estradiol].
Rachev E
Akush Ginekol (Sofiia); 1995; 34(1):41-2. PubMed ID: 7485806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
